Macular thickness after cataract surgery with intracameral cefuroxime.

Purpose: To determine whether the use of prophylactic intracameral cefuroxime during phacoemulsification cataract surgery is associated with increased macular thickening in the postoperative period.

Setting: Hull and East Yorkshire Eye Hospital, Hull, United Kingdom.

Methods: In this prospective randomized double-masked clinical study, the study group received 1 mg of intracameral cefuroxime and the control group received intracameral balanced salt solution only.